GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...

Researchers analysed more than 400,000 social media posts in a bid to identify lesser-known issues linked to widely used GLP-1 medications semaglutide and tirzepatide.

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...

Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from ...

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...